AstraZeneca: Colorectal Neoplasms trials
The registry lists 29 Colorectal Neoplasms studies with AstraZeneca as lead sponsor. 2 are open to participants now and 7 have results posted.
Phase 1 13Phase 2 19Phase 3 3No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationRecruitingNCT05877599Phase 1
- Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)RecruitingNCT05489211Phase 2
- A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid TumoursTerminatedNCT05397171Phase 1/2Results posted
- Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) StatusCompletedNCT00912743Phase 2Results posted
- A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOXCompletedNCT00494221Phase 1/2Results posted
- Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00399035Phase 3Results posted
- First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOXCompletedNCT00384176Phase 2/3Results posted
- A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.CompletedNCT00378482Phase 2Results posted
- Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)CompletedNCT00278889Phase 2Results posted
- ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid TumorsCompletedNCT06973161
- A Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerActive, not recruitingNCT06792695Phase 2
- A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D MutationTerminatedNCT06599502Phase 1
- Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsActive, not recruitingNCT06218914Phase 1
- A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid TumoursActive, not recruitingNCT06147037Phase 1
- First in Human Study of AZD9592 in Solid TumorsActive, not recruitingNCT05647122Phase 1
- A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid TumoursTerminatedNCT05363605Phase 1/2
- Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesActive, not recruitingNCT04644068Phase 1/2
- A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing TumorsActive, not recruitingNCT04482309Phase 2
- Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRCWithdrawnNCT04145193Phase 2
- A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid TumorsCompletedNCT03811652Phase 1
- A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid MalignanciesCompletedNCT02740985Phase 1
- A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid TumoursCompletedNCT02586987Phase 1
- Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With ColorecCompletedNCT01116271Phase 2
- Phase II Efficacy Study of AZD6244 in Colorectal CancerCompletedNCT00514761Phase 2
- Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After TreatmentCompletedNCT00313794Phase 2
- IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo FailureCompletedNCT00242788Phase 1/2
- A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal CarcinomaCompletedNCT00234429Phase 2/3
- Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerWithdrawnNCT00233623Phase 2
- Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.TerminatedNCT00065117Phase 2